JSJanusz Sauermann

Janusz Sauermann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Janusz Sauermann has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The role of electroconvulsive therapy (ECT) in the treatment of a life-threatening condition in a patient with paranoid schizophrenia a case report in the context of limited availability of therapy in Poland

    by Patrycja Najda, Oliwia Rdzanek, Emilia Kamizela, Janusz Sauermann, Sylwiusz Niedobylski, Michał Próchnicki

    Introduction: Schizophrenia represents a leading cause of acute psychotic episodes and is frequently associated with profound social dysfunction and in severe cases, it may result in conditions posing an immediate threat to life. Management typically involves biological treatment modalities combined with psychotherapy; however, a subset of patients develops treatment resistance. Electroconvulsive therapy (ECT) remains a key intervention for overcoming pharmacoresistance, despite its limited availability in Poland. Material and method: The article present a clinical case report and a literature review based on the MEDLINE database. Results: The case study concerns a 20-year-old woman who developed a severe, prolonged psychotic state as a consequence of treatment refusal. Owing to the critical clinical condition, confirmed pharmacoresistance and progressive secondary malnutrition, ECT was initiated as a life-saving measure under the principle of medical necessity. A marked improvement in mental status was observed after the first session. Upon completion of the full ECT course, the patient was discharged home in logical contact, without psychotic symptoms, with a diagnosis of paranoid schizophrenia. Conclusions: The case supports the conclusion that ECT is an effective method for overcoming pharmacoresistance in acute psychosis and may constitute one of the most efficacious therapeutic options. In certain situations, the benefits of ECT outweigh those of pharmacotherapy alone. This case is of particular clinical relevance as it illustrates a life-saving application of ECT. The literature review further confirms the efficacy and safety of this treatment modality. Nevertheless, access to ECT in Poland remains insufficient and excessive ancillary procedural requirements reduce its cost-effectiveness, contributing to the persistence of this limitation.

  • Open Access

    Porphyria in pregnancy with exacerbation after delivery due to COVID-19

    by Aleksandra Jartych, Karolina Michalska, Izabela Oleksak, Janusz Sauermann, Anna Jamroz-Wiśniewska, Konrad Rejdak

    We present a case of acute intermittent porphyria (AIP) diagnosed in a pregnant woman with subsequent exacerbation after delivery due to COVID-19 infection. The patient’s symptoms manifested with acute neurovisceral attacks - abdominal pain followed by flaccid quadriparesis, sensory disturbances, hypertension and disturbance in electrolyte levels. The blood plasma test and a 24-hour urine collection revealed increased levels of urine porphobilinogen, 5-aminolevulinic acid and uroporphyrins, which led to the diagnosis of AIP. The patient received i.v. human hemin with positive outcome. After delivery she was again admitted to the hospital due to abdominal pain and trunk hyperesthesia that occurred after a mild course of COVID-19 infection. The second administration of human hemin led to the improvement of the patient's condition. The aim of this case report is to indicate that even with severe risk factors of AIP such as infection and pregnancy, proper diagnostics can increase the chance of quick recovery.